Acumen Pharmaceuticals, Inc.

8-K Regulation FD disclosure; Other events Jun 16, 2026 8-K Shareholder vote results Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 26, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 16, 2026 8-K Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2025 8-K Director or officer change; Regulation FD disclosure Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Jul 15, 2025 8-K Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 13, 2024 8-K Shareholder vote results Jun 5, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 26, 2024 8-K Results of operations (earnings release) Mar 26, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 19, 2024 8-K Director or officer change; Regulation FD disclosure Feb 1, 2024 8-K Regulation FD disclosure Jan 12, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Regulation FD disclosure Dec 4, 2023 8-K Regulation FD disclosure Nov 13, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 13, 2023 8-K Entered a material agreement Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2023 8-K Entered a material agreement; Other events Jul 20, 2023